Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/13/26 16:46 | 3/11/26 | DYN | Health | Drug | Pharmaceutical Preparations | Posner Brian S | MA | D | 2 | P | 84 | 16.78 | 0 | 5 | 59 | 14 | D | |||||||||||||||
3/13/26 16:35 | 3/11/26 | DYN | Health | Drug | Pharmaceutical Preparations | Kersten Dirk | MA | D | 2 | S.m | -15,680 | 19.16 | 0 | -818 | 4,774 | I | ||||||||||||||||
3/6/26 16:10 | 3/5/26 | DYN | Health | Drug | Pharmaceutical Preparations | Friedl-Naderer Johanna | MA | O | Chief Co | 1 | S | -2 | 14.90 | 0 | 0 | 0 | 155 | D | ||||||||||||||
3/6/26 16:09 | 3/5/26 | DYN | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | Chief Me | 1 | S | -13 | 14.90 | 0 | -1 | 172 | D | |||||||||||||||
3/6/26 16:08 | 3/5/26 | DYN | Health | Drug | Pharmaceutical Preparations | Cox John | MA | DO | CEO,P | 1 | S | -41 | 14.90 | 0 | -3 | 446 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |